26th Annual Lynn Sage Breast Cancer Symposium: 13 Posts Not to Miss

The 26th Annual Lynn Sage Breast Cancer Symposium was held from 24-27 October, in person in Chicago.

The Lynn Sage Breast Cancer Symposium recognized as one of the most valuable meetings for breast cancer practitioners worldwide. This multidisciplinary continuing medical education (CME) program spanned 3.5 days and featured presentations and interactive Q/A sessions focused on the latest advancements in breast cancer management.

For over 25 years, the symposium has brought together leading national and international medical, surgical, and radiation oncologists to share cutting-edge technology and approaches in breast cancer treatment. This year’s event promised an exceptional lineup of internationally recognized faculty who presented the latest research findings and engaged in real-time discussions with attendees.

The symposium emphasized the importance of multidisciplinary collaboration for effective patient management in breast cancer care, making it an essential gathering for healthcare professionals dedicated to improving outcomes in this field.

Polly Grieger Rossi:

“Great start of the 26th Annual Lynn Sage Breast Cancer Symposium – Thanks to our Chair – William Gradishar and Monica Morrow for hosting the 26th Annual Lynn Sage Breast Cancer Symposium.”

Huiping Liu:

“Great learning day LSBC24 with inspiring leaders William Gradishar, Drs. Monica Morrow, Armando Giuliano, John Hayes, Virginia Kaklamani and dinner with Leonidas Platanias, Lurie Cancer Center, Ben Ho Park, Vanderbilt-Ingram Cancer Center and LSBC24 Chairs, Speakers, organizers of LynnSage Breast Cancer Symposium.”

Leonidas Platanias:

“Presenting the Chicago Sister cities awards to physicians from all over the world attending the Lynn Sage Symposium of ⁦Lurie Cancer Center.”

Mariana Bustamante Eduardo:

⁩”Great session on Breast Pathology for the Non-Pathologist at LSBC24 Happy to learn more about AI applications in Breast Pathology. Great talk from Dr. Lee Cooper.”

Bob Riter:

“Dr. Sunil Badve speaking with Komen Advocates at the Lynn Sage Breast Cancer Symposium.”

Huiping Liu:

“Fantastic LSBC24 meeting final session on Future Directions in Breast Cancer Care. Thanks to the Chair William Gradishar, speakers Ben Ho Park and others, Susan G. Komen, patient advocates in science Meryl, Debbie Breast Cancer Symposium.”

Ellie Proussaloglou:

“As always, Dr. E. Mittendorf presenting a fantastic overview of vaccine development for breast cancer treatment- the up and down along with exciting future directions – targeted antigens, role of germline genetic PVs and mRNA.”

Stacey Tinianov:

“Oh, it’s a little spicy in here

Following Dr. Costa’s pro eBC surveillance pitch (incl. QoL sentiment from CRC patients), Dr. Virginia Kaklamani now argues risk/benefit of ctDNA doesn’t pan out as ‘good screening tool’.

NOTE: We don’t know how to handle micromets disease.”

Elizabeth Ann Mittendorf:

“Outstanding overview of phyllodes tumors and current management recommendations from Laura Rosenberger.”

Diana Jaber:

“Some highlights from two great sessions today at LSBC24 highlighting inmunotherapy and management options in HR-positive Breast Cancer.”

Stacey Tinianov:

“Spent the last few days at LSBC24 with these phenomenal research advocates (and others!) We all agree that there has been tremendous progress in many areas, but there is still a compelling need to Make Cancer Less Shitty.”

Ellie Proussaloglou:

“Tari King with a thoughtful, evidence-based review of DCIS care – eager to see results of BABYTEARS   Can RT be omitted?

Is surgery over-treatment for some DCIS?

How can we safely dose-reduce endocrine treatment with maximal benefit?”

Luis Z. Blanco:

“Closing off the Breast Pathology for the Non-Pathologists session at LSBC24 is Northwestern Pathology division head and session moderator Dr. Kalliopi Siziopikou (my mentor)! Beyond BRCA: Pathological Features of Breast Carcinomas Associated with Other Genes.”